Literature DB >> 11736872

The effect of cotrimoxazole coadministrated with antituberculous drugs on serum transaminases in HIV-infected adults from the Ivory Coast.

E Messou, X Anglaret, D Bonard, H Kouabena, T N'Dri-Yoman, M Dosso, F Dabis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11736872      PMCID: PMC2014601          DOI: 10.1046/j.0306-5251.2001.01483.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Provisional WHO/UNAIDS recommendations on the use of contrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa.

Authors: 
Journal:  Afr Health Sci       Date:  2001-08       Impact factor: 0.927

2.  Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.

Authors:  I Medina; J Mills; G Leoung; P C Hopewell; B Lee; G Modin; N Benowitz; C B Wofsy
Journal:  N Engl J Med       Date:  1990-09-20       Impact factor: 91.245

3.  Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group.

Authors:  X Anglaret; G Chêne; A Attia; S Toure; S Lafont; P Combe; K Manlan; T N'Dri-Yoman; R Salamon
Journal:  Lancet       Date:  1999-05-01       Impact factor: 79.321

4.  Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial.

Authors:  S Z Wiktor; M Sassan-Morokro; A D Grant; L Abouya; J M Karon; C Maurice; G Djomand; A Ackah; K Domoua; A Kadio; A Yapi; P Combe; O Tossou; T H Roels; E M Lackritz; D Coulibaly; K M De Cock; I M Coulibaly; A E Greenberg
Journal:  Lancet       Date:  1999-05-01       Impact factor: 79.321

5.  Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus.

Authors:  J R Ungo; D Jones; D Ashkin; E S Hollender; D Bernstein; A P Albanese; A E Pitchenik
Journal:  Am J Respir Crit Care Med       Date:  1998-06       Impact factor: 21.405

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.